Ads
related to: schizophrenia latest newsdoconsumer.com has been visited by 100K+ users in the past month
bargaininsight.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
The U.S. Food and Drug Administration (FDA) on Friday approved a new drug used for treating schizophrenia in adults, according to a press release. “This drug takes the first new approach to ...
About Schizophrenia Schizophrenia is a chronic, progressive and severely debilitating mental disorder that affects how one thinks, feels and acts. 2 Patients experience an array of symptoms, which may include delusions, hallucinations, disorganized speech or behavior, and impaired cognitive ability. 2,3,4 Approximately 1% of the world’s ...
Bristol Myers Squibb said on Saturday data from late-stage studies of its experimental schizophrenia drug showed it helped reduce symptoms of the disorder without the common side effect of weight ...
News. Science & Tech. Shopping. Sports. Weather. 24/7 Help. ... has declined to approve its drug to regulate behavioral changes in patients with schizophrenia that can cause social withdrawal and ...
More than 40 percent of all people with schizophrenia end up in supervised group housing, nursing homes or hospitals. Another 6 percent end up in jail, usually for misdemeanors or petty crimes, while an equal proportion end up on the streets. Among researchers, schizophrenia has long been known as the “graveyard of psychiatric research.”
Minerva believed that the findings of this second trial supported the claim that the drug was an effective agent for the treatment of negative symptoms in schizophrenia. However, in October 2022, FDA sent Minerva a refusal to file letter pertaining to the New Drug Application for roluperidone for treating negative symptoms in schizophrenia ...
Ads
related to: schizophrenia latest newsdoconsumer.com has been visited by 100K+ users in the past month
bargaininsight.com has been visited by 10K+ users in the past month